Kestra Medical plans 13,015-share stock sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. (KMTS) reports a planned sale of 13,015 shares of common stock through Merrill Lynch on or about 07/31/2026, to be traded on NASDAQ. These shares relate to performance share unit awards that vested on 07/17/2026 and were granted under the issuer’s equity compensation plan.
Alfred J. Ford previously sold 5,936 shares of common stock for $135,120.73 on 07/30/2026 and 8,681 shares for $196,284.58 on 07/31/2026.
Key Figures
Key Terms
equity compensation plan financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is disclosed for Kestra Medical Technologies (KMTS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.